期刊文献+

微小隐孢子虫TSP3蛋白质的表达与功能 被引量:3

Expression and Function of Cryptosporidium parvum TSP3 Protein
原文传递
导出
摘要 通过对微小隐孢子虫TSP3基因克隆构建原核表达载体,纯化TSP3 His-tag重组蛋白质免疫新西兰家兔,间接ELISA方法检测特异性血清效价并纯化多克隆抗体。纯化TSP3 GST-tag重组蛋白质并与HCT-8细胞进行共孵育,通过Western blot与间接ELISA检测细胞黏附特性。结果表明:成功构建了微小隐孢子虫p ET-TSP3和p GEX-TSP3重组表达质粒,并用亲和层析法成功纯化出较高质量的重组蛋白质。Cp TSP3重组蛋白质具有良好免疫原性,并能与HCT-8细胞黏附。 By cloning Cryptosporidium parvum TSP3, prokaryotic expression vector was constructed, and to immunize New Zealand rabbits, TSP3-His tag of recombinant protein was purified. By indirect ELISA method, specific serum titers were detected and polyclonal antibodies were purified. The pu- rified TSP3-GST tag of recombinant protein was incubated with HCT-8 cells by Western blot and in- direct ELISA cell adhesion properties. This study successfully constructed Cryptosporidium parvum pET-TSP3 and pGEX-TSP3 recombinant plasmid, and by affinity chromatography successfully puri- fied recombinant proteins of high quality. CpTSP3 recombinant proteins are of good immunogenicity and can bind HCT-8.
出处 《吉林农业大学学报》 CAS CSCD 北大核心 2015年第2期226-231,236,共7页 Journal of Jilin Agricultural University
基金 国家自然科学基金项目(31072125)
关键词 微小隐孢子虫 TSP3 原核表达 多克隆抗体 细胞黏附 Cryptosporidium parvum TSP3 prokaryotic expression polyclonal antibody cell adhesion
  • 相关文献

参考文献15

  • 1Upton S J, Curren W L. The species of Cryptosporidium (Api- complexa: Cryptosporidiidae) infecting mammals[J] .The Jour- nal of Parasitology, 1985, 71(5) : 625-629.
  • 2Mitchell S Abrahamsen, Thomas J Templeton, Shinichiro Eno- moto, et al. Complete genome sequence of the apicomplexan, Cryptosporidium parvum [ J ]. Science, 2004, 304 (16) : 441- 445.
  • 3Wanyiri jane, Ward honorine. Molecular basis of Cryptosporidi- urn-host cell interactions: recent advances and future prospects [ J] .Future Microbiology ,2006,1 (2) :201-208.
  • 4Dabremetz J F, Garciareguet N, Conseil, et al.Apical organelles and host cell invasion by Apicomplexa [ J ]. Int J Parasitol, 1998,28: 1007-1013.
  • 5Wetzel D M, Schmidt J, Kuhlenschmidt M S,et al. Gliding mo- tility leads to active cellular invasion by Cryptosporidium parvum sporozoites [ J ].Infect Immun, 2005,73 (9) : 5379-5387.
  • 6Sibleyld. Intracellular parasite invasion strategies [ J ]. Science, 2004, 304:248-253.
  • 7Deng M, Templeton T J, London N R, et al. Cryptosporidium parvum genes containing thrombospondin type 1 domains [ J ]. Infection and Immunity, 2002, 70(12) : 6987-6995.
  • 8Cowper B, Matthews S, Tomley F. The molecular basis for the distinct host and tissue tropisms of coccidian parasites[ J]. Mo- lecular and Biochemical Parasitology, 2012, 186: 1-10.
  • 9Savvas saouros, Bryn edward-jones, Matthias reiss, et al.A novel galectin-like domain from Toxoplasma gondii micronemal pro- tein 1 assists the folding, assembly, and transport of a cell adhe- sion complex [ J ]. The Journal of Biological Chemistry, 2005, 280(46) :38583-38591.
  • 10O'connor R M, Burns P B, Ha-ngoc T, et al. Polymorphic mucin antigens CpMuc4 and CpMuc5 are integral to Crypto- sporidium parvum infection in vitro [ J ]. Eukaryotic Cell, 2009, 8(4) : 461-469.

二级参考文献25

  • 1蒋金书,赵亚荣,胡景辉.隐孢子虫病的研究进展[J].中国兽医杂志,1994,20(10):38-42. 被引量:37
  • 2Doganci T, Araz E, Ensari A, et al. Detection of Cryptosporidium parvum infection in childhood using various techniques[J]. Med Sci Monit, 2002,8( 12 ) : 223-226.
  • 3Chen X M, O'Hara S P, Huang B Q, et al. Localized glucose and water influx facilitates Cryptosporidium parvum cellular invasion by means of modulation of host-cell membrane protrusion[ J]. Proc Natl Acad Sci, 102(18) :6338-6343.
  • 4Caccio SM. Molecular epidemiology of human cryptosporidiosis [ J]. Parassitologia,2005,47(2) : 185-192.
  • 5Putignani L. The unusual architecture and predicted function of the mitochondrion organelle in Cryptosporidium parvum and hominis species: the strong paradigm of the structure-function relationship [ J]. Parassitologia, 2005,47 (2) : 217-225.
  • 6Petersen C, Barnes D A, Gousset L. Cryptosporidium parvum GP900, a Unique Invasion Protein[J]. The journal of Eukaryotic Microbiology, 1997,44(6) : 89-90.
  • 7de Graaf D C, Spano F, Perry F, et al. Speculation on whether a vaccine against cryptosporidiosis is a reality or fantasy[J]. International Journal for Parasitology, 1999,29(8) : 1289-1306.
  • 8Yu Q, Li J, Zhang X, et al. Induction of immune responses in mice by a DNA vaccine encoding Cryptosporidium parvum Cpl2 and Cp21 and its effect against homologous oocyst challenge[J]. Veterinary Parasitology, 2010,172(2) : 172-177.
  • 9Liu K, Zai D, Zhang D, et al. Divalent Cp15-23 vaccine enhances immune responses and protection against Cryptosporidium parvum infection[ J]. Parasite Immunology, 2010,32(5) : 335-344.
  • 10Belli S I, Walker R A, Flowers S A. Global protein expression analysis in apicomplexan parasities: current status[J].Proteomics, 2005,5(4) :918-924.

共引文献1

同被引文献15

  • 1Chuang I, Richie T L. World Malaria Retmrt 2010: documen- ting progress towards malaria eradication[ J]. Expert Review of Vaccines, 2012, 11(1) :39-41.
  • 2World Health Organization. World Malaria Report 2013 [ EB/ OL]. [ 2014-10-20 ]. http ://www. who. int/malaria/publica- tions/w orld_malaria_report_2013/report/en/.
  • 3Vitoria M, Granich R, Gilks C F, et al. The global fight a- gainst HIV/AIDS, tuberculosis, and malaria: current status and future perspectives[ J ]. American Society for Clinical Pa- thology , 2009, 131 (6) : 844-848.
  • 4Richards J S, Beeson J G. The future for blood-stage vaecines against malaria [ J ]. Immunology and Cell Biology, 2009, 87 (5) :377-390.
  • 5Beeson J G, Brown G V. Pathogenesis of Plasmodium falcipa- rum malaria : the roles of parasite adhesion and antigenic varia- tion [ J ]. Cellular and Molecular Life Sciences, 2002, 59 ( 2 ) : 258-271.
  • 6Richards J S, Arumugam T U, R.eiling L, et al. Identification and prioritization of merozoite antigens as targets of protective human immunity to Plasmodiumfalciparum malaria for vaccine and biomarker development [ J ]. Journal of Immunology, 2013, 191 (2) :795-809.
  • 7Fowkes F J I, Richards J S, Simpson J A, et al. The relation- ship between anti-merozoite antibodies and incidence of Plas- modium falciparum malaria: A systematic review and meta-a- nalysis[J]. PLoS Medicine, 2010, 7(1):e1000218.
  • 8Egan A F, Morris J, Bamish G, et al. Clinical immunity to Plasmodium falciparum malaria is associated with serum anti- bodies to the 19-kDa C-terminal fragment of the memzoite sur- face antigen, PfMSP-I [ J]. lnfeeious Diseases, 1996, 173 ( 3 ) : 765-769.
  • 9Taylor R R, Allen S J, Greenwood B M, et al. IgG3 antibod- ies to Plasmodium falciparum merozoite surface protein 2 (MSP2) : increasing prevalence with age and association with clinical immunity to malaria[J ]. Tropical Medicine and Hy- giene, 1998, 58(4) :406-413.
  • 10Roussilhon C, Oeuvray C, Mtfller-Graf C, et al. Long-term clinical protection fromfalciparum malaria is strongly associat- ed with IgG3 antibodies to merozoite surface protein 3 [ J ]. PLoS Medicine, 2007, 4( 11 ) :e320.

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部